[1] Sandrasegaran K,Tahir B,Patel A,et al.The usefulness of diffusion-weighted imaging in the characterization of liver lesions in patients with cirrhosis.Clin Radiol,2013,68: 708-715. [2] 张莉,马雪英,梁丰丽,等.ADC值联合肝纤四项对肝纤维化分期的评估.实用放射学杂志,2016,32: 52-55. [3] 段雪飞.中国《慢性乙型肝炎防治指南(2015版)》要点解读.中华全科医师杂志,2016,15: 409-412. [4] 中华医学会传染病与寄生虫病学分会、肝病学分会.病毒性肝炎防治方案.中华肝脏病杂志,2000,8:324-329. [5] Hong Y,Shi Y,Liao W,et al.Relative ADC measurement for liver fibrosis diagnosis in chronic hepatitis B using spleen/renal cortex as the reference organs at 3 T.Clin Radiol,2014,69: 581-588. [6] 李柏丽,黄文琪,许金超.慢性乙型肝炎患者肝组织病理特征及其相关因素分析.肝脏,2016,21: 462-467,468. [7] Fowell AJ,Iredale JP.Emerging therapies for liver fibrosis. Dig Dis,2006,24: 174-183. [8] Cece H,Ercan A,Yildiz S,et al.The use of DWI to assess spleen and liver quantitative ADC changes in the detection of liver fibrosis stages in chronic viral hepatitis.Eur J Radiol,2013,82: e307-e312. [9] 郑婉静,郑贤应,曹代荣,等.脂肪抑制T2WI和MRI增强在慢性乙型肝炎活动期中的诊断价值.临床放射学杂志,2016,35: 1039-1042. [10] 赵广强,翁苓苓,陈义磊,等.弥散加权成像与弥散张量成像评价肝纤维化的实验研究.医学影像学杂志,2016,26: 99-104. |